Skip to main content

Dalfopristin and Quinupristin Injection Shortage

Last Updated: September 26, 2022
Status: Current

Products Affected - Description
    • Synercid lyophilized powder for injection, Pfizer, 350 mg/150 mg, vial, 10 count, NDC 61570-0260-10 - discontinued
Reason for the Shortage
    • Pfizer discontinued Synercid in early-2022.
    • There are no other suppliers of the product.
Available Products
    • There are no presentations available

Estimated Resupply Dates

    • Pfizer has discontinued Synercid.


Updated September 26, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 8, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.